SidaGhanaV1, PascalFrancis, Corpus, bibRecord, 000010

Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa

Identifieur interne : 000010 ( PascalFrancis/Corpus ); précédent : 000009; suivant : 000011

Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa

Auteurs : David Chadwick ; Alastair Stanley ; Stephen Sarfo ; Lambert Appiah ; Michael Ankcorn ; Geraldine Foster ; Uli Schwab ; Richard Phillips ; Anna M. Geretti

Source :

AIDS : (London) [ 0269-9370 ] ; 2013.

RBID : Pascal:13-0117484

Descripteurs français

Pascal (Inist)
- SIDA, Hépatite virale B, Antiviral, Chimiothérapie, Antirétroviral, Afrique Ouest, Virus immunodéficience humaine.

English descriptors

KwdEn :
- AIDS, Antiretroviral agent, Antiviral, Chemotherapy, Human immunodeficiency virus, Viral hepatitis B, West Africa.

Abstract

This study evaluated the outcome of first-line anti-retroviral therapy among 35 Ghanaians with occult HBV/HIV co-infection, comparing them over 2 years to 120 patients with HBsAg+ HBV/HIV co-infection and 230 patients without HBV coinfection. Increases in CD4 cell count and BMI were similar, whereas elevations of hepatic transaminases were more frequent in both the occult HBV and HBsAg+ patients. Occult HBV/HIV co-infection appears not to impact adversely on response to antiretroviral therapy in Ghana.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0269-9370`
A03		`1`		`@0 AIDS : (Lond.)`
A05				`@2 27`
A06				`@2 1`
A08	`01`	`1`	`ENG`	`@1 Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa`
A11	`01`	`1`		`@1 CHADWICK (David)`
A11	`02`	`1`		`@1 STANLEY (Alastair)`
A11	`03`	`1`		`@1 SARFO (Stephen)`
A11	`04`	`1`		`@1 APPIAH (Lambert)`
A11	`05`	`1`		`@1 ANKCORN (Michael)`
A11	`06`	`1`		`@1 FOSTER (Geraldine)`
A11	`07`	`1`		`@1 SCHWAB (Uli)`
A11	`08`	`1`		`@1 PHILLIPS (Richard)`
A11	`09`	`1`		`@1 GERETTI (Anna M.)`
A14	`01`			`@1 Centre for Clinical Infection, The James Cook University Hospital @2 Middlesbrough @3 GBR @Z 1 aut. @Z 2 aut. @Z 5 aut.`
A14	`02`			`@1 Komfo Anokye Teaching Hospital @2 Kumasi @3 GHA @Z 3 aut. @Z 4 aut. @Z 8 aut.`
A14	`03`			`@1 Institute of Global Health, University of Liverpool @3 GBR @Z 6 aut. @Z 9 aut.`
A14	`04`			`@1 Department of Infection and Tropical Medicine, Royal Victoria Infirmary @2 Newcastle-upon-Tyne @3 GBR @Z 7 aut.`
A20				`@1 139-144`
A21				`@1 2013`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 22094 @5 354000182588230170`
A44				`@0 0000 @1 © 2013 INIST-CNRS. All rights reserved.`
A45				`@0 9 ref.`
A47	`01`	`1`		`@0 13-0117484`
A60				`@1 P @3 CR`
A61				`@0 A`
A64	`01`	`1`		`@0 AIDS : (London)`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 This study evaluated the outcome of first-line anti-retroviral therapy among 35 Ghanaians with occult HBV/HIV co-infection, comparing them over 2 years to 120 patients with HBsAg+ HBV/HIV co-infection and 230 patients without HBV coinfection. Increases in CD4 cell count and BMI were similar, whereas elevations of hepatic transaminases were more frequent in both the occult HBV and HBsAg+ patients. Occult HBV/HIV co-infection appears not to impact adversely on response to antiretroviral therapy in Ghana.
C02	`01`	`X`		`@0 002B05C02D`
C02	`02`	`X`		`@0 002B02S05`
C02	`03`	`X`		`@0 002B05C02G`
C03	`01`	`X`	`FRE`	`@0 SIDA @5 01`
C03	`01`	`X`	`ENG`	`@0 AIDS @5 01`
C03	`01`	`X`	`SPA`	`@0 SIDA @5 01`
C03	`02`	`X`	`FRE`	`@0 Hépatite virale B @5 02`
C03	`02`	`X`	`ENG`	`@0 Viral hepatitis B @5 02`
C03	`02`	`X`	`SPA`	`@0 Hepatitis vírica B @5 02`
C03	`03`	`X`	`FRE`	`@0 Antiviral @5 04`
C03	`03`	`X`	`ENG`	`@0 Antiviral @5 04`
C03	`03`	`X`	`SPA`	`@0 Antiviral @5 04`
C03	`04`	`X`	`FRE`	`@0 Chimiothérapie @5 05`
C03	`04`	`X`	`ENG`	`@0 Chemotherapy @5 05`
C03	`04`	`X`	`SPA`	`@0 Quimioterapia @5 05`
C03	`05`	`X`	`FRE`	`@0 Antirétroviral @5 08`
C03	`05`	`X`	`ENG`	`@0 Antiretroviral agent @5 08`
C03	`05`	`X`	`SPA`	`@0 Antiretroviral @5 08`
C03	`06`	`X`	`FRE`	`@0 Afrique Ouest @2 NG @5 09`
C03	`06`	`X`	`ENG`	`@0 West Africa @2 NG @5 09`
C03	`06`	`X`	`SPA`	`@0 Africa occidental @2 NG @5 09`
C03	`07`	`X`	`FRE`	`@0 Virus immunodéficience humaine @2 NW @5 10`
C03	`07`	`X`	`ENG`	`@0 Human immunodeficiency virus @2 NW @5 10`
C03	`07`	`X`	`SPA`	`@0 Human immunodeficiency virus @2 NW @5 10`
C07	`01`	`X`	`FRE`	`@0 Virose`
C07	`01`	`X`	`ENG`	`@0 Viral disease`
C07	`01`	`X`	`SPA`	`@0 Virosis`
C07	`02`	`X`	`FRE`	`@0 Infection`
C07	`02`	`X`	`ENG`	`@0 Infection`
C07	`02`	`X`	`SPA`	`@0 Infección`
C07	`03`	`X`	`FRE`	`@0 Traitement`
C07	`03`	`X`	`ENG`	`@0 Treatment`
C07	`03`	`X`	`SPA`	`@0 Tratamiento`
C07	`04`	`X`	`FRE`	`@0 Afrique @2 NG`
C07	`04`	`X`	`ENG`	`@0 Africa @2 NG`
C07	`04`	`X`	`SPA`	`@0 Africa @2 NG`
C07	`05`	`X`	`FRE`	`@0 Lentivirus @2 NW`
C07	`05`	`X`	`ENG`	`@0 Lentivirus @2 NW`
C07	`05`	`X`	`SPA`	`@0 Lentivirus @2 NW`
C07	`06`	`X`	`FRE`	`@0 Retroviridae @2 NW`
C07	`06`	`X`	`ENG`	`@0 Retroviridae @2 NW`
C07	`06`	`X`	`SPA`	`@0 Retroviridae @2 NW`
C07	`07`	`X`	`FRE`	`@0 Virus @2 NW`
C07	`07`	`X`	`ENG`	`@0 Virus @2 NW`
C07	`07`	`X`	`SPA`	`@0 Virus @2 NW`
C07	`08`	`X`	`FRE`	`@0 Immunodéficit @5 37`
C07	`08`	`X`	`ENG`	`@0 Immune deficiency @5 37`
C07	`08`	`X`	`SPA`	`@0 Inmunodeficiencia @5 37`
C07	`09`	`X`	`FRE`	`@0 Immunopathologie @5 39`
C07	`09`	`X`	`ENG`	`@0 Immunopathology @5 39`
C07	`09`	`X`	`SPA`	`@0 Inmunopatología @5 39`
C07	`10`	`X`	`FRE`	`@0 Pathologie de l'appareil digestif @5 40`
C07	`10`	`X`	`ENG`	`@0 Digestive diseases @5 40`
C07	`10`	`X`	`SPA`	`@0 Aparato digestivo patología @5 40`
C07	`11`	`X`	`FRE`	`@0 Pathologie du foie @5 41`
C07	`11`	`X`	`ENG`	`@0 Hepatic disease @5 41`
C07	`11`	`X`	`SPA`	`@0 Hígado patología @5 41`
N21				`@1 091`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 13-0117484 INIST
ET :	Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa
AU :	CHADWICK (David); STANLEY (Alastair); SARFO (Stephen); APPIAH (Lambert); ANKCORN (Michael); FOSTER (Geraldine); SCHWAB (Uli); PHILLIPS (Richard); GERETTI (Anna M.)
AF :	Centre for Clinical Infection, The James Cook University Hospital/Middlesbrough/Royaume-Uni (1 aut., 2 aut., 5 aut.); Komfo Anokye Teaching Hospital/Kumasi/Ghana (3 aut., 4 aut., 8 aut.); Institute of Global Health, University of Liverpool/Royaume-Uni (6 aut., 9 aut.); Department of Infection and Tropical Medicine, Royal Victoria Infirmary/Newcastle-upon-Tyne/Royaume-Uni (7 aut.)
DT :	Publication en série; Correspondance, lettre; Niveau analytique
SO :	AIDS : (London); ISSN 0269-9370; Etats-Unis; Da. 2013; Vol. 27; No. 1; Pp. 139-144; Bibl. 9 ref.
LA :	Anglais
EA :	This study evaluated the outcome of first-line anti-retroviral therapy among 35 Ghanaians with occult HBV/HIV co-infection, comparing them over 2 years to 120 patients with HBsAg+ HBV/HIV co-infection and 230 patients without HBV coinfection. Increases in CD4 cell count and BMI were similar, whereas elevations of hepatic transaminases were more frequent in both the occult HBV and HBsAg+ patients. Occult HBV/HIV co-infection appears not to impact adversely on response to antiretroviral therapy in Ghana.
CC :	002B05C02D; 002B02S05; 002B05C02G
FD :	SIDA; Hépatite virale B; Antiviral; Chimiothérapie; Antirétroviral; Afrique Ouest; Virus immunodéficience humaine
FG :	Virose; Infection; Traitement; Afrique; Lentivirus; Retroviridae; Virus; Immunodéficit; Immunopathologie; Pathologie de l'appareil digestif; Pathologie du foie
ED :	AIDS; Viral hepatitis B; Antiviral; Chemotherapy; Antiretroviral agent; West Africa; Human immunodeficiency virus
EG :	Viral disease; Infection; Treatment; Africa; Lentivirus; Retroviridae; Virus; Immune deficiency; Immunopathology; Digestive diseases; Hepatic disease
SD :	SIDA; Hepatitis vírica B; Antiviral; Quimioterapia; Antiretroviral; Africa occidental; Human immunodeficiency virus
LO :	INIST-22094.354000182588230170
ID :	13-0117484

Links to Exploration step

Pascal:13-0117484

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa</title>
<author><name sortKey="Chadwick, David" sort="Chadwick, David" uniqKey="Chadwick D" first="David" last="Chadwick">David Chadwick</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Clinical Infection, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stanley, Alastair" sort="Stanley, Alastair" uniqKey="Stanley A" first="Alastair" last="Stanley">Alastair Stanley</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Clinical Infection, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sarfo, Stephen" sort="Sarfo, Stephen" uniqKey="Sarfo S" first="Stephen" last="Sarfo">Stephen Sarfo</name>
<affiliation><inist:fA14 i1="02"><s1>Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Appiah, Lambert" sort="Appiah, Lambert" uniqKey="Appiah L" first="Lambert" last="Appiah">Lambert Appiah</name>
<affiliation><inist:fA14 i1="02"><s1>Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ankcorn, Michael" sort="Ankcorn, Michael" uniqKey="Ankcorn M" first="Michael" last="Ankcorn">Michael Ankcorn</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Clinical Infection, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Foster, Geraldine" sort="Foster, Geraldine" uniqKey="Foster G" first="Geraldine" last="Foster">Geraldine Foster</name>
<affiliation><inist:fA14 i1="03"><s1>Institute of Global Health, University of Liverpool</s1>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schwab, Uli" sort="Schwab, Uli" uniqKey="Schwab U" first="Uli" last="Schwab">Uli Schwab</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Infection and Tropical Medicine, Royal Victoria Infirmary</s1>
<s2>Newcastle-upon-Tyne</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name>
<affiliation><inist:fA14 i1="02"><s1>Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Geretti, Anna M" sort="Geretti, Anna M" uniqKey="Geretti A" first="Anna M." last="Geretti">Anna M. Geretti</name>
<affiliation><inist:fA14 i1="03"><s1>Institute of Global Health, University of Liverpool</s1>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">13-0117484</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 13-0117484 INIST</idno>
<idno type="RBID">Pascal:13-0117484</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000010</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa</title>
<author><name sortKey="Chadwick, David" sort="Chadwick, David" uniqKey="Chadwick D" first="David" last="Chadwick">David Chadwick</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Clinical Infection, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stanley, Alastair" sort="Stanley, Alastair" uniqKey="Stanley A" first="Alastair" last="Stanley">Alastair Stanley</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Clinical Infection, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Sarfo, Stephen" sort="Sarfo, Stephen" uniqKey="Sarfo S" first="Stephen" last="Sarfo">Stephen Sarfo</name>
<affiliation><inist:fA14 i1="02"><s1>Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Appiah, Lambert" sort="Appiah, Lambert" uniqKey="Appiah L" first="Lambert" last="Appiah">Lambert Appiah</name>
<affiliation><inist:fA14 i1="02"><s1>Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ankcorn, Michael" sort="Ankcorn, Michael" uniqKey="Ankcorn M" first="Michael" last="Ankcorn">Michael Ankcorn</name>
<affiliation><inist:fA14 i1="01"><s1>Centre for Clinical Infection, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Foster, Geraldine" sort="Foster, Geraldine" uniqKey="Foster G" first="Geraldine" last="Foster">Geraldine Foster</name>
<affiliation><inist:fA14 i1="03"><s1>Institute of Global Health, University of Liverpool</s1>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schwab, Uli" sort="Schwab, Uli" uniqKey="Schwab U" first="Uli" last="Schwab">Uli Schwab</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Infection and Tropical Medicine, Royal Victoria Infirmary</s1>
<s2>Newcastle-upon-Tyne</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name>
<affiliation><inist:fA14 i1="02"><s1>Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Geretti, Anna M" sort="Geretti, Anna M" uniqKey="Geretti A" first="Anna M." last="Geretti">Anna M. Geretti</name>
<affiliation><inist:fA14 i1="03"><s1>Institute of Global Health, University of Liverpool</s1>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">AIDS : (London)</title>
<title level="j" type="abbreviated">AIDS : (Lond.)</title>
<idno type="ISSN">0269-9370</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">AIDS : (London)</title>
<title level="j" type="abbreviated">AIDS : (Lond.)</title>
<idno type="ISSN">0269-9370</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS</term>
<term>Antiretroviral agent</term>
<term>Antiviral</term>
<term>Chemotherapy</term>
<term>Human immunodeficiency virus</term>
<term>Viral hepatitis B</term>
<term>West Africa</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>SIDA</term>
<term>Hépatite virale B</term>
<term>Antiviral</term>
<term>Chimiothérapie</term>
<term>Antirétroviral</term>
<term>Afrique Ouest</term>
<term>Virus immunodéficience humaine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This study evaluated the outcome of first-line anti-retroviral therapy among 35 Ghanaians with occult HBV/HIV co-infection, comparing them over 2 years to 120 patients with HBsAg+ HBV/HIV co-infection and 230 patients without HBV coinfection. Increases in CD4 cell count and BMI were similar, whereas elevations of hepatic transaminases were more frequent in both the occult HBV and HBsAg+ patients. Occult HBV/HIV co-infection appears not to impact adversely on response to antiretroviral therapy in Ghana.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0269-9370</s0>
</fA01>
<fA03 i2="1"><s0>AIDS : (Lond.)</s0>
</fA03>
<fA05><s2>27</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>CHADWICK (David)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>STANLEY (Alastair)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SARFO (Stephen)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>APPIAH (Lambert)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>ANKCORN (Michael)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>FOSTER (Geraldine)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>SCHWAB (Uli)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>PHILLIPS (Richard)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>GERETTI (Anna M.)</s1>
</fA11>
<fA14 i1="01"><s1>Centre for Clinical Infection, The James Cook University Hospital</s1>
<s2>Middlesbrough</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Komfo Anokye Teaching Hospital</s1>
<s2>Kumasi</s2>
<s3>GHA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Institute of Global Health, University of Liverpool</s1>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Infection and Tropical Medicine, Royal Victoria Infirmary</s1>
<s2>Newcastle-upon-Tyne</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>139-144</s1>
</fA20>
<fA21><s1>2013</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>22094</s2>
<s5>354000182588230170</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2013 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>9 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>13-0117484</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CR</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>AIDS : (London)</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>This study evaluated the outcome of first-line anti-retroviral therapy among 35 Ghanaians with occult HBV/HIV co-infection, comparing them over 2 years to 120 patients with HBsAg+ HBV/HIV co-infection and 230 patients without HBV coinfection. Increases in CD4 cell count and BMI were similar, whereas elevations of hepatic transaminases were more frequent in both the occult HBV and HBsAg+ patients. Occult HBV/HIV co-infection appears not to impact adversely on response to antiretroviral therapy in Ghana.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B05C02D</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B02S05</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B05C02G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>SIDA</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>AIDS</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>SIDA</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Hépatite virale B</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Viral hepatitis B</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Hepatitis vírica B</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Antiviral</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Antiviral</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Antiviral</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Antirétroviral</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Antiretroviral agent</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Antiretroviral</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Afrique Ouest</s0>
<s2>NG</s2>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>West Africa</s0>
<s2>NG</s2>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Africa occidental</s0>
<s2>NG</s2>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Virus immunodéficience humaine</s0>
<s2>NW</s2>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Traitement</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Treatment</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Tratamiento</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Afrique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Africa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Africa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Immunodéficit</s0>
<s5>37</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Immune deficiency</s0>
<s5>37</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Inmunodeficiencia</s0>
<s5>37</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Immunopathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Immunopathology</s0>
<s5>39</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Inmunopatología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Pathologie de l'appareil digestif</s0>
<s5>40</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>Digestive diseases</s0>
<s5>40</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Aparato digestivo patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="11" i2="X" l="FRE"><s0>Pathologie du foie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="11" i2="X" l="ENG"><s0>Hepatic disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="11" i2="X" l="SPA"><s0>Hígado patología</s0>
<s5>41</s5>
</fC07>
<fN21><s1>091</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 13-0117484 INIST</NO>
<ET>Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa</ET>
<AU>CHADWICK (David); STANLEY (Alastair); SARFO (Stephen); APPIAH (Lambert); ANKCORN (Michael); FOSTER (Geraldine); SCHWAB (Uli); PHILLIPS (Richard); GERETTI (Anna M.)</AU>
<AF>Centre for Clinical Infection, The James Cook University Hospital/Middlesbrough/Royaume-Uni (1 aut., 2 aut., 5 aut.); Komfo Anokye Teaching Hospital/Kumasi/Ghana (3 aut., 4 aut., 8 aut.); Institute of Global Health, University of Liverpool/Royaume-Uni (6 aut., 9 aut.); Department of Infection and Tropical Medicine, Royal Victoria Infirmary/Newcastle-upon-Tyne/Royaume-Uni (7 aut.)</AF>
<DT>Publication en série; Correspondance, lettre; Niveau analytique</DT>
<SO>AIDS : (London); ISSN 0269-9370; Etats-Unis; Da. 2013; Vol. 27; No. 1; Pp. 139-144; Bibl. 9 ref.</SO>
<LA>Anglais</LA>
<EA>This study evaluated the outcome of first-line anti-retroviral therapy among 35 Ghanaians with occult HBV/HIV co-infection, comparing them over 2 years to 120 patients with HBsAg+ HBV/HIV co-infection and 230 patients without HBV coinfection. Increases in CD4 cell count and BMI were similar, whereas elevations of hepatic transaminases were more frequent in both the occult HBV and HBsAg+ patients. Occult HBV/HIV co-infection appears not to impact adversely on response to antiretroviral therapy in Ghana.</EA>
<CC>002B05C02D; 002B02S05; 002B05C02G</CC>
<FD>SIDA; Hépatite virale B; Antiviral; Chimiothérapie; Antirétroviral; Afrique Ouest; Virus immunodéficience humaine</FD>
<FG>Virose; Infection; Traitement; Afrique; Lentivirus; Retroviridae; Virus; Immunodéficit; Immunopathologie; Pathologie de l'appareil digestif; Pathologie du foie</FG>
<ED>AIDS; Viral hepatitis B; Antiviral; Chemotherapy; Antiretroviral agent; West Africa; Human immunodeficiency virus</ED>
<EG>Viral disease; Infection; Treatment; Africa; Lentivirus; Retroviridae; Virus; Immune deficiency; Immunopathology; Digestive diseases; Hepatic disease</EG>
<SD>SIDA; Hepatitis vírica B; Antiviral; Quimioterapia; Antiretroviral; Africa occidental; Human immunodeficiency virus</SD>
<LO>INIST-22094.354000182588230170</LO>
<ID>13-0117484</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000010 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000010 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:13-0117484
   |texte=   Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa
}}

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024

	Le SIDA au Ghana (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA au Ghana (serveur d'exploration)

Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa

Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri